Earlier this week, Massachusetts voters rejected Proposition 8, declining to become the first state to repeal voter-approved commercial recreational marijuana sales. During the campaign, opponents argued that roughly $300 million in marijuana tax revenue helps fund drug treatment and teen prevention programs. This argument exposes the self-defeating tradeoff facing states: governments collect tax revenue from commercialized narcotics while trying to pay for the severe harm those products inflict on their citizens.
The human toll of commercialization is escalating rapidly. Emergency rooms in legal jurisdictions report a sharp rise in acute cannabis toxicity, cyclical vomiting, dehydration, electrolyte disturbances, acute kidney injury, and behavioral crises. Tragically, adolescents and young adults who use cannabis are twice as likely to be diagnosed with bipolar or psychotic disorders.
This debate is also playing out at the federal level. Pushing to reclassify marijuana to Schedule III will not fix these public health problems; it primarily hands commercial operators massive tax relief.
For parents, schools, and lawmakers, the stakes extend far beyond adult choice and state budgets. Commercial markets shape what young people see as normal. Lawmakers must confront the ultimate question: is state tax revenue worth the risk to our children and communities?
